Location: Boston, MA
CIK: 0001595855 · Show all filings
Period: Q2 2016 (← Previous) (Next →)
Filing Date: Aug 12, 2016
Total Value: $150M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AXGN | AXOGEN INC | 2,120,000 | $14.59M | 9.7% | $3.33 | +70.0% | COM | 05463X106 |
| — | MEDGENICS INC | 1,950,000 | $10.82M | 7.2% | $5.38 | — | COM NEW | 58436Q203 |
| — | ARIAD PHARMACEUTICALS INC | 1,250,000 | $9.238M | 6.2% | $6983.72 | — | COM | 04033A100 |
| — | FIBROGEN INC | 330,000 | $5.415M | 3.6% | $25.62 | — | COM | 31572Q808 |
| — | PROTALIX BIOTHERAPEUTICS INC | 8,200,000 | $5.248M | 3.5% | $1.32 | — | COM | 74365AAB7 |
| — | BLUEPRINT MEDICINES CORP | 250,000 | $5.063M | 3.4% | $23.53 | — | COM | 09627Y109 |
| — | INOTEK PHARMACEUTICALS CORP | 645,000 | $4.799M | 3.2% | $5.17 | — | COM | 45780VAA0 |
| — | IMPRIMIS PHARMACEUTICALS INC | 1,267,500 | $4.766M | 3.2% | $2946.31 | — | COM NEW | 45323A201 |
| CDXS | CODEXIS INC | 1,178,500 | $4.749M | 3.2% | $1.98 | +84.7% | COM | 192005106 |
| — | ADAMAS PHARMACEUTICALS INC | 300,000 | $4.542M | 3.0% | $18.87 | — | COM | 00548A106 |
| — | FOAMIX PHARMACEUTICALS LTD | 695,000 | $4.413M | 2.9% | $7.68 | — | SHS | M46135105 |
| — | CARA THERAPEUTICS INC | 835,000 | $4.016M | 2.7% | $8.65 | — | COM | 140755109 |
| — | AMARIN CORP PLC | 1,760,000 | $3.802M | 2.5% | $2.34 | — | SPONS ADR NEW | 023111206 |
| AGIO | AGIOS PHARMACEUTICALS | 85,000 | $3.561M | 2.4% | $42.75 | +15.5% | COM | 00847X104 |
| — | HORIZON PHARMA PLC | 200,000 | $3.294M | 2.2% | $16.47 | — | COM | G4617B105 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 65,000 | $3.179M | 2.1% | $45.89 | +41.0% | COM | 90400D108 |
| MGNX | MACROGENICS INC | 112,000 | $3.023M | 2.0% | $22.55 | 0.0% | COM | 556099109 |
| — | IMMUNOMEDICS INC | 1,300,000 | $3.016M | 2.0% | $2.62 | — | COM | 452907108 |
| — | INTEC PHARMA LTD JERUSALEM | 650,000 | $2.989M | 2.0% | $5.56 | — | SHS | M53644106 |
| — | AMAG PHARMACEUTICALS INC | 120,000 | $2.87M | 1.9% | $44.20 | — | COM | 00163U106 |
| — | CHIMERIX INC | 675,000 | $2.653M | 1.8% | $5.11 | — | COM | 16934W106 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 125,000 | $2.546M | 1.7% | $8.76 | +102.4% | COM | 868459108 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 152,000 | $2.522M | 1.7% | $16.59 | — | COM | 37890U108 |
| XENE | XENON PHARMACEUTICALS INC | 410,000 | $2.419M | 1.6% | $8.69 | -21.1% | COM | 98420N105 |
| — | EDGE THERAPEUTICS INC | 225,600 | $2.281M | 1.5% | $9.32 | — | COM | 279870109 |
| — | LION BIOTECHNOLOGIES INC | 260,000 | $2.106M | 1.4% | $8.10 | — | COM | 53619R102 |
| — | CYNAPSUS THERAPEUTICS INC | 125,000 | $2.094M | 1.4% | $15.24 | — | COM PAR NO PAR | 23257Y859 |
| — | PARATEK PHARMACEUTICALS INC | 146,700 | $2.041M | 1.4% | $13.91 | — | COM | 699374302 |
| — | NABRIVA THERAPEUTICS AG | 270,000 | $2.025M | 1.4% | $9.49 | — | SPONSORED ADR | 62957M104 |
| — | AQUINOX PHARMACEUTICALS INC | 295,000 | $1.953M | 1.3% | $6.62 | — | COM | 03842B101 |
| EGRX | EAGLE PHARMACEUTICALS INC | 50,000 | $1.94M | 1.3% | $71.99 | -42.2% | COM | 269796108 |
| — | ZOGENIX INC | 240,000 | $1.932M | 1.3% | $8.05 | — | COM NEW | 98978L105 |
| — | TRILLIUM THERAPEUTICS INC | 195,000 | $1.751M | 1.2% | $9.00 | — | COM NEW | 89620X506 |
| — | SERES THERAPEUTICS INC | 57,500 | $1.67M | 1.1% | $29.04 | — | COM | 81750R102 |
| CTMX | CYTOMX THERAPEUTICS INC | 160,000 | $1.634M | 1.1% | $11.41 | 0.0% | COM | 23284F105 |
| — | TONIX PHARMACEUTICALS HLDG C | 800,000 | $1.592M | 1.1% | $1.99 | — | COM NEW | 890260201 |
| — | AFFIMED NV | 595,000 | $1.476M | 1.0% | $13.23 | — | COM | N01045108 |
| — | INNOCOLL HOLDINGS PLC | 265,000 | $1.46M | 1.0% | $5.51 | — | SHS | G4783X105 |
| — | AURIS MED HLDG AG | 340,000 | $1.425M | 1.0% | $4.86 | — | COM | H03579101 |
| OCUL | OCULAR THERAPEUTIX INC | 260,000 | $1.287M | 0.9% | $9.91 | 0.0% | COM | 67576A100 |
| — | PROTEOSTASIS THERAPEUTICS IN | 105,000 | $1.274M | 0.9% | $12.13 | — | COM | 74373B109 |
| — | CORIUM INTL INC | 360,000 | $1.249M | 0.8% | $8.06 | — | COM | 21887L107 |
| — | TENAX THERAPEUTICS INC | 465,000 | $1.19M | 0.8% | $3.68 | — | COM | 88032L100 |
| TGTX | TG THERAPEUTICS INC | 175,000 | $1.061M | 0.7% | $12.98 | -37.4% | COM | 88322Q108 |
| — | EVOKE PHARMA INC | 130,000 | $891K | 0.6% | $474.90 | — | COM | 30049G104 |
| — | NEURODERM LTD | 52,500 | $853K | 0.6% | $14.69 | — | ORD SHS | M74231107 |
| — | CIDARA THERAPEUTICS INC | 43,000 | $443K | 0.3% | $10.30 | — | COM | 171757107 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 40,000 | $326K | 0.2% | $8.13 | — | SPONDS ADR | 00653A107 |
| — | BIOLINERX LTD | 250,000 | $223K | 0.1% | $1426.15 | — | SPONSORED ADR | 09071M106 |